Bristol Myers Squibb plans to inject $40 billion into U.S. operations over the next five years, mixing business ambition with ...

US pharma major Bristol Myers Squibb is planning a massive $40 billion investment in the country over the next five years.

Bristol Myers Squibb has appointment Cari Gallman as executive vice president, general counsel and chief policy officer, ...

Gallman takes on the role of EVP, General Counsel and Chief Policy Officer, following Sandra Leung’s retirement after 33 ...

A new executive order aims to smooth the path for getting U.S. manufacturing facilities up and running; HHS says it will ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

Merck broke ground on a $1B, 470K SF biotech facility last month at the Chestnut Run Innovation & Science Park in Wilmington, ...

Jeremy Walsh is now heading up artificial intelligence and information technology in a newly created position at the FDA.

The $40 billion investment will be spread across various R&D and manufacturing areas over the next five years.

Bristol Myers Squibb has appointed Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer, ...

Bristol Myers Squibb helmsman Chris Boerner joined a growing list of life sciences leaders announcing major U.S. investments ...

In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing ...